LEXX
Lexaria Bioscience·NASDAQ
--
--(--)
--
--(--)
LEXX fundamentals
During Q1 2026, Lexaria Bioscience (LEXX) reported revenue of --, a YoY change of 0.00%. Net income was -1.60M, a YoY change of 40.98%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | TTM |
|---|
Start Date | Sep 1, 2019 | Dec 1, 2019 | Mar 1, 2020 | Jun 1, 2020 | Sep 1, 2020 | Dec 1, 2020 | Mar 1, 2021 | Jun 1, 2021 | Sep 1, 2021 | Dec 1, 2021 | Mar 1, 2022 | Jun 1, 2022 | Sep 1, 2022 | Dec 1, 2022 | Mar 1, 2023 | Jun 1, 2023 | Sep 1, 2023 | Dec 1, 2023 | Mar 1, 2024 | Jun 1, 2024 | Sep 1, 2024 | Dec 1, 2024 | Mar 1, 2025 | Jun 1, 2025 | Sep 1, 2025 | -- |
End Date | Nov 30, 2019 | Feb 29, 2020 | May 31, 2020 | Aug 31, 2020 | Nov 30, 2020 | Feb 28, 2021 | May 31, 2021 | Aug 31, 2021 | Nov 30, 2021 | Feb 28, 2022 | May 31, 2022 | Aug 31, 2022 | Nov 30, 2022 | Feb 28, 2023 | May 31, 2023 | Aug 31, 2023 | Nov 30, 2023 | Feb 29, 2024 | May 31, 2024 | Aug 31, 2024 | Nov 30, 2024 | Feb 28, 2025 | May 31, 2025 | Aug 31, 2025 | Nov 30, 2025 | -- |
Fiscal Year-End | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | -- |
Revenue | 10.33K -- | 37.55K -- | 36.42K -- | 63.99K -- | 295.66K +2761.56% | 192.01K +411.35% | 204.06K +460.24% | 31.02K -51.52% | 13.88K -95.31% | 30.65K -84.04% | 99.72K -51.13% | 111.15K +258.31% | 97.73K +604.14% | 20.02K -34.67% | 77.71K -22.07% | 30.74K -72.34% | 151.28K +54.78% | 145.00K +624.09% | 84.00K +8.10% | 84.00K +173.25% | 183.92K +21.58% | 174.00K +20.00% | 174.00K +107.14% | 174.00K +107.14% | -- -- | -- -- |
Sales and Services Revenue | 10.33K -- | 37.55K -- | 36.42K -- | 63.99K -- | 295.66K +2761.56% | 192.01K +411.35% | 204.06K +460.24% | 26.44K -58.69% | 13.88K -95.31% | 30.65K -84.04% | 99.72K -51.13% | 23.75K -10.16% | 97.73K +604.14% | 20.02K -34.67% | 77.71K -22.07% | -4.50K -118.95% | 150.38K +53.86% | 145.00K +624.09% | 84.00K +8.10% | 83.10K +1946.67% | 183.92K +22.31% | 174.00K +20.00% | 174.00K +107.14% | 174.00K +109.39% | 0 -100.00% | 522.00K -- |
Other Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.58K -- | -- -- | -- -- | -- -- | 87.40K +1806.19% | -- -- | -- -- | -- -- | 35.24K -59.68% | 900 -- | -- -- | -- -- | 900 -97.45% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- |
Cost of Revenue | 7.85K -- | 58.11K -- | 20.32K -- | 13.10K -- | 64.48K +721.06% | 30.57K -47.39% | 59.99K +195.24% | 20.31K +55.03% | 5.57K -91.36% | 6.39K -79.11% | 18.64K -68.94% | 41.25K +103.11% | 15.79K +183.57% | 2.96K -53.69% | 12.75K -31.60% | -- -- | 4.82K -69.47% | -- -- | -- -- | -- -- | 2.72K -43.59% | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 175.35K -- | -- -- | -- -- | -- -- | 71.84K -59.03% | -- -- | -- -- | 12.75K -- | 0 -100.00% | 4.82K -- | 0 -- | 0 -100.00% | 0 -- | 2.72K -43.59% | 0 -- | 0 -- | 0 -- | 0 -100.00% | -- -- |
Gross Profit | 2.48K -- | -20.56K -- | 16.10K -- | 50.89K -- | 231.18K +9225.45% | 161.44K +885.31% | 144.07K +794.60% | 10.71K -78.95% | 8.31K -96.41% | 24.26K -84.97% | 81.08K -43.72% | 69.90K +552.55% | 81.94K +886.04% | 17.07K -29.66% | 64.96K -19.88% | 30.74K -56.02% | 146.46K +78.74% | 145.00K +749.59% | 84.00K +29.31% | 84.00K +173.25% | 181.20K +23.73% | 174.00K +20.00% | 174.00K +107.14% | 174.00K +107.14% | 0 -100.00% | 522.00K -- |
Operating Expenses | 978.59K -- | 1.04M -- | 1.43M -- | 913.65K -- | 944.30K -3.50% | -256.75K -124.66% | 2.71M +90.04% | 1.31M +43.75% | 2.01M +113.05% | 1.47M +673.68% | 2.50M -7.79% | 818.45K -37.68% | 1.78M -11.65% | 1.34M -8.98% | 2.47M -1.34% | 1.14M +39.88% | 1.29M -27.67% | 813.00K -39.36% | 1.83M -25.91% | 2.29M +99.77% | 2.87M +123.39% | 2.93M +259.78% | 3.92M +114.81% | 2.86M +25.16% | 1.57M -45.21% | 11.29M -- |
Selling, General and Administrative Expenses | 234.99K -- | 213.97K -- | 256.88K -- | 3.27M -- | 752.04K +220.03% | 1.09M +409.20% | 2.26M +778.30% | 873.58K -73.26% | 1.55M +106.52% | 1.20M +9.88% | 1.75M -22.55% | 462.26K -47.08% | 947.87K -38.97% | 644.51K -46.17% | 825.18K -52.77% | 644.45K +39.41% | 711.11K -24.98% | 567.23K -11.99% | 1.25M +51.95% | 1.32M +104.80% | 918.69K +29.19% | 1.24M +118.45% | 1.21M -3.74% | 980.48K -25.71% | 902.29K -1.79% | 4.33M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.97M -- | -- -- | -- -- | -- -- | 4.96M -0.23% | -- -- | -- -- | 825.18K -- | 644.45K -87.01% | 711.11K -- | 567.23K -- | 1.25M +51.95% | 1.32M +104.80% | 918.69K +29.19% | 1.24M +118.45% | 1.21M -3.74% | 980.48K -25.71% | 902.29K -1.79% | 4.33M -- |
Research and Development Expenses | 107.46K -- | 186.56K -- | 24.56K -- | 68.50K -- | 192.26K +78.91% | 176.40K -5.45% | 454.44K +1750.56% | 439.79K +542.06% | 458.71K +138.59% | 275.69K +56.29% | 752.10K +65.50% | 356.19K -19.01% | 829.49K +80.83% | 696.18K +152.53% | 1.64M +118.14% | 500.41K +40.49% | 574.49K -30.74% | 245.78K -64.70% | 573.09K -65.07% | 967.21K +93.28% | 1.95M +239.99% | 1.69M +585.95% | 2.72M +374.18% | 1.88M +94.59% | 671.34K -65.63% | 6.96M -- |
Other Operating Expenses | 636.13K -- | 640.59K -- | 1.14M -- | -2.42M -- | -- -- | -1.52M -337.70% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -976.11K -- | -1.06M -- | -1.41M -- | -862.76K -- | -713.12K +26.94% | 418.19K +139.39% | -2.57M -81.99% | -1.30M -50.99% | -2.00M -180.95% | -1.45M -446.42% | -2.42M +5.77% | -748.55K +42.54% | -1.70M +15.38% | -1.32M +8.63% | -2.40M +0.72% | -1.11M -48.84% | -1.14M +32.81% | -668.00K +49.53% | -1.74M +27.40% | -2.20M -97.74% | -2.69M -136.20% | -2.75M -311.83% | -3.75M -115.18% | -2.69M -22.04% | -1.57M +41.52% | -10.76M -- |
Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -764.61K -- | -73.89K -- | 12.99K -- | 17.30K -- | -134.90K +82.36% | -45.90K +37.88% | 15.27K +17.59% | -41.39K -339.28% | 16.49K +112.23% | -15.92K +65.31% | 34.04K +122.89% | -40.19K +2.92% | -8.63K -152.33% | -22.08K -38.69% | -36.86K -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.86K -- | 77.78K -- | -- -- | 15.27K -- | -41.39K -2330.23% | 79.33K +2.01% | -- -- | 34.04K +122.88% | -40.38K +2.46% | 22.27K -71.93% | -- -- | -- -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -764.61K -- | -77.63K -- | -2.00K -- | -- -- | -221.69K +71.01% | -53.22K +31.45% | -- -- | -- -- | -69.83K +68.50% | -15.93K +70.06% | -- -- | -- -- | -33.71K +51.72% | -22.09K -38.67% | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -3.74K -- | -14.99K -- | -15.44K -- | -9.02K -- | -7.32K -95.64% | 1 +100.01% | 0 +100.00% | -6.99K +22.44% | -11 +99.85% | 0 -100.00% | -190 -- | -2.82K +59.73% | -12 -9.09% | -3.02K -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 3.74K -- | -- -- | 15.44K -- | 9.02K -- | 7.32K +95.64% | -1 -- | 0 -100.00% | 6.99K -22.44% | 11 -99.85% | 0 +100.00% | 190 -- | 2.82K -59.73% | 12 +9.09% | 3.02K -- |
Pretax Income From Continuing Operations | -976.11K -- | -1.06M -- | -1.41M -- | -862.76K -- | -713.12K +26.94% | 418.19K +139.39% | -2.57M -81.99% | -1.30M -50.99% | -2.00M -180.95% | -1.45M -446.42% | -2.42M +5.77% | -1.51M -16.16% | -1.77M +11.69% | -1.31M +9.53% | -2.38M +1.44% | -1.25M +17.46% | -1.19M +33.02% | -652.73K +50.20% | -1.78M +25.14% | -2.19M -75.06% | -2.71M -128.40% | -2.72M -316.25% | -3.79M -112.44% | -2.70M -23.35% | -1.60M +41.04% | -10.80M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.79K -- | -- -- |
Income from Discontinued Operations | 51.34K -- | 64.18K -- | 19.61K -- | -19.61K -- | 3.00K -94.16% | -25.00K -138.95% | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -924.76K -- | -997.49K -- | -1.39M -- | -882.38K -- | -710.12K +23.21% | 393.19K +139.42% | -2.57M -84.56% | -1.30M -47.63% | -2.00M -182.13% | -1.45M -468.44% | -2.42M +5.77% | -1.51M -16.16% | -1.77M +11.69% | -1.31M +9.53% | -2.38M +1.44% | -1.25M +17.46% | -1.19M +33.02% | -652.73K +50.20% | -1.78M +25.14% | -2.19M -75.06% | -2.71M -128.40% | -2.72M -316.25% | -3.79M -112.44% | -2.70M -23.35% | -1.60M +40.98% | -10.80M -- |
Net Income Attributable to Minority Interests | -17.45K -- | -47.15K -- | -29.27K -- | -56.75K -- | -14.09K +19.24% | -10.92K +76.84% | -9.55K +67.36% | -124.57K -119.52% | -10.32K +26.74% | -22.90K -109.66% | -35.41K -270.62% | -45.70K +63.32% | -13.36K -29.41% | -12.51K +45.38% | -12.06K +65.94% | -9.70K +78.78% | -5.71K +57.23% | -3.19K +74.46% | -2.62K +78.29% | -1.78K +81.63% | -2.93K +48.75% | -3.76K -17.72% | -1.51K +42.19% | -1.39K +21.95% | -2.50K +14.78% | -9.16K -- |
Net Income Attributable to Owners of the Company | -907.31K -- | -950.34K -- | -1.36M -- | -825.63K -- | -696.03K +23.29% | 404.11K +142.52% | -2.56M -87.82% | -1.18M -42.69% | -1.99M -186.36% | -1.43M -452.82% | -2.38M +6.81% | -1.47M -24.56% | -1.76M +11.90% | -1.30M +8.95% | -2.37M +0.48% | -1.24M +15.55% | -1.18M +32.84% | -649.54K +49.96% | -1.78M +24.87% | -2.18M -76.29% | -2.70M -129.26% | -2.71M -317.71% | -3.79M -112.67% | -2.70M -23.39% | -1.60M +41.01% | -10.79M -- |
Net Income Attributable to Common Stockholders | -907.31K -- | -950.34K -- | -1.36M -- | -825.63K -- | -696.03K +23.29% | 404.11K +142.52% | -2.56M -87.82% | -1.18M -42.69% | -1.99M -186.36% | -1.43M -452.82% | -2.38M +6.81% | -1.47M -24.56% | -1.76M +11.90% | -1.30M +8.95% | -2.37M +0.48% | -1.24M +15.55% | -1.18M +32.84% | -649.54K +49.96% | -1.78M +24.87% | -2.18M -76.29% | -2.70M -129.26% | -2.71M -317.71% | -3.79M -112.67% | -2.70M -23.39% | -1.60M +41.01% | -10.79M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | -- -- | 4.37K -- | -25.00K -- | -1.24K -- | 2.05K -- | -3.17K -172.62% | -95.25K -281.05% | 37.17K +3097.82% | 10.74K +423.80% | -5.74K -80.91% | -53.09K -- |
Total Comprehensive Income | -924.76K -- | -997.49K -- | -1.39M -- | -882.38K -- | -710.12K +23.21% | 393.19K +139.42% | -2.57M -84.56% | -1.30M -47.63% | -- -- | -- -- | -- -- | 0 +100.00% | -1.77M -- | -1.31M -- | -2.38M -- | -1.25M -- | -1.17M +33.59% | -677.73K +48.29% | -1.79M +25.09% | -2.18M -74.90% | -2.71M -130.63% | -2.81M -314.95% | -3.75M -110.21% | -2.69M -22.98% | -1.60M +40.84% | -10.86M -- |
Total Comprehensive Income Attributable to Minority Interests | -17.45K -- | -47.15K -- | -29.27K -- | -56.75K -- | -14.09K +19.24% | -10.92K +76.84% | -9.55K +67.36% | 34.57K +160.92% | -- -- | -- -- | -- -- | -- -- | -13.36K -- | -12.51K -- | -12.06K -- | -9.70K -- | -5.71K +57.23% | -3.19K +74.46% | -2.62K +78.29% | -1.78K +81.63% | -2.93K +48.75% | -3.76K -17.72% | -1.51K +42.19% | -1.39K +21.95% | -2.50K +14.78% | -9.16K -- |
Total Comprehensive Income Attributable to Owners of the Company | -907.31K -- | -950.34K -- | -1.36M -- | -825.63K -- | -696.03K +23.29% | 404.11K +142.52% | -2.56M -87.82% | -1.34M -61.97% | -- -- | -- -- | -- -- | -7.38M -452.16% | -1.76M -- | -1.30M -- | -2.37M -- | -1.24M +83.22% | -1.17M +33.09% | -674.54K +48.04% | -1.78M +24.82% | -2.18M -76.12% | -2.71M -130.38% | -2.81M -316.35% | -3.75M -110.44% | -2.69M -23.02% | -1.60M +40.86% | -10.85M -- |
Basic EPS | -0.33 -- | -0.38 -- | -0.5 -- | -- -- | -0.24 +27.27% | 0.09 +123.68% | -0.5 -- | -0.21 -- | -0.35 -45.83% | -0.25 -377.78% | -0.41 +18.00% | -0.25 -19.05% | -0.3 +14.29% | -0.22 +12.00% | -0.37 +9.76% | -0.15 +40.00% | -0.13 +56.67% | -0.06 +72.73% | -0.13 +64.86% | -0.14 +6.67% | -0.16 -23.08% | -0.15 -150.00% | -0.21 -61.54% | -0.14 -- | -0.07 +56.25% | -0.57 -- |
Basic EPS from Continuing Operations | -0.35 -- | -0.4 -- | -0.5 -- | -- -- | -0.24 +31.43% | 0.1 +125.00% | -0.5 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.37 -- | -- -- | -0.13 -- | -0.06 -- | -0.13 +64.86% | -- -- | -0.16 -23.08% | -0.15 -150.00% | -0.21 -61.54% | -- -- | -0.07 +56.25% | -- -- |
Basic EPS from Discontinued Operations | 0.02 -- | 0.02 -- | -0.01 -- | -- -- | 0 -100.00% | -0.01 -150.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Diluted EPS | -0.33 -- | -0.38 -- | -0.5 -- | -- -- | -0.24 +27.27% | 0.09 +123.68% | -0.5 -- | -- -- | -0.35 -45.83% | -0.25 -377.78% | -0.41 +18.00% | -- -- | -0.3 +14.29% | -0.22 +12.00% | -0.37 +9.76% | -- -- | -0.13 +56.67% | -0.06 +72.73% | -0.13 +64.86% | -- -- | -0.16 -23.08% | -0.15 -150.00% | -0.21 -61.54% | -- -- | -0.07 +56.25% | -- -- |
Diluted EPS from Continuing Operations | -0.35 -- | -0.4 -- | -0.5 -- | -- -- | -0.24 +31.43% | 0.1 +125.00% | -0.5 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.37 -- | -- -- | -0.13 -- | -0.06 -- | -0.13 +64.86% | -- -- | -0.16 -23.08% | -0.15 -150.00% | -0.21 -61.54% | -- -- | -0.07 +56.25% | -- -- |
Diluted EPS from Discontinued Operations | 0.02 -- | 0.02 -- | -0.01 -- | -- -- | 0 -100.00% | -0.01 -150.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
You can ask Aime
What factors drove the changes in Lexaria Bioscience's revenue and profit?What is Lexaria Bioscience's gross profit margin?What is the market's earnings forecast for Lexaria Bioscience next quarter?What does Lexaria Bioscience do and what are its main business segments?What is Lexaria Bioscience's latest dividend and current dividend yield?Did Lexaria Bioscience beat or miss consensus estimates last quarter?What were the key takeaways from Lexaria Bioscience’s earnings call?What were the key takeaways from Lexaria Bioscience's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
